INBX Earnings Inhibrx Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q1 2026 | 2026-03-31 | -2.15 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -9.04 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -6.93 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -4.65 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.80 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | 112.62 | 2026-03-19 | 10-K |
| Q3 2025 | 2024-09-30 | 117.09 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | 122.75 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -5.77 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -20.48 | 2025-03-17 | 10-K |
| Q3 2024 | 2023-09-30 | -13.19 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -8.80 | 2024-08-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.